ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1089

Decreased B Cell Activation-Induced Apoptosis in Cells Overexpressing Interferon Regulatory Factor 5 (IRF5), a Gene Associated with Risk for Systemic Lupus Erythematosus and Other Autoimmune Diseases

Brian Poole1, Caleb Cornaby2, Kalare Eberting2, Wesley Cheney2, Grant Walker2, Craig Smith2, Tosh Dowling2 and Emily Mello2, 1Brigham Young University, Provo, UT, 2Microbiology and Molecular Biology, Brigham Young University, Provo, UT

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: apoptosis and interferons, B cell tolerance, B cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The transcription factor Interferon Regulatory Factor 5 (IRF5) plays a crucial role in the functioning of several cell types such as macrophages, dendritic, and B cells. In Systemic Lupus Erythematosus (SLE), the IRF5 gene locus has been identified as a risk factor with various single nucleotide polymorphisms (SNPs) that demonstrate a strong correlation with disease development. It has been demonstrated that these polymorphisms cause increased production of IRF5 protein. In this study we investigate the effects of IRF5 overexpression in B cells on apoptosis. We hypothesized that overexpression of IRF5 would decrease activation-induced apoptosis. This would reduce tolerance and likely contribute to the development of lupus or other autoimmune diseases.

Methods: A lentivirus transduction system was engineered by cloning the human IRF5 gene into the bicistronic lentivirus pUltra-Chili, which expresses the reporter dTomato along with IRF5. Naïve B cells were isolated from healthy donors and transduced with our lentivirus construct with and without IRF5. The cells were then stimulated with IgG anti-Igm to induce activation. As an added control, a population of un-transduced naïve B cells was also stimulated. Forty-two hours post stimulation, apoptosis was measured by Annexin V staining and flow cytometry, with naïve B cell populations being gated on dTomato expression. Statistical analysis was done using the Wilcoxon signed-rank and p values with an alpha less than 0.05 were considered significant.

Results: Anti-IgM treated naïve B cells showed increased apoptosis compared to non-stimulated samples as expected. Comparing naïve B cells overexpressing IRF5 with naïve B cells treated with the empty vector, the IRF5 overexpressing cells demonstrated, on average, 46.5 % less apoptosis (p < 0.05).

Conclusion: These results support our hypothesis that overexpression of IRF5, which is a result of lupus-associated IRF5 SNPs, decreases apoptosis in activated B cells after B cell receptor engagement. This could provide a greater risk of breaking self-tolerance in individuals with the IRF5 risk haplotype.


Disclosure: B. Poole, None; C. Cornaby, None; K. Eberting, None; W. Cheney, None; G. Walker, None; C. Smith, None; T. Dowling, None; E. Mello, None.

To cite this abstract in AMA style:

Poole B, Cornaby C, Eberting K, Cheney W, Walker G, Smith C, Dowling T, Mello E. Decreased B Cell Activation-Induced Apoptosis in Cells Overexpressing Interferon Regulatory Factor 5 (IRF5), a Gene Associated with Risk for Systemic Lupus Erythematosus and Other Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/decreased-b-cell-activation-induced-apoptosis-in-cells-overexpressing-interferon-regulatory-factor-5-irf5-a-gene-associated-with-risk-for-systemic-lupus-erythematosus-and-other-autoimmune-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-b-cell-activation-induced-apoptosis-in-cells-overexpressing-interferon-regulatory-factor-5-irf5-a-gene-associated-with-risk-for-systemic-lupus-erythematosus-and-other-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology